KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Change in Cash (2016 - 2026)

AbbVie has reported Change in Cash over the past 14 years, most recently at -$400.0 million for Q4 2025.

  • Quarterly Change in Cash rose 76.92% to -$400.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$295.0 million through Dec 2025, up 95.95% year-over-year, with the annual reading at -$295.0 million for FY2025, 95.95% up from the prior year.
  • Change in Cash was -$400.0 million for Q4 2025 at AbbVie, up from -$838.0 million in the prior quarter.
  • Over five years, Change in Cash peaked at $5.3 billion in Q1 2024 and troughed at -$5.9 billion in Q3 2024.
  • The 5-year median for Change in Cash is -$436.5 million (2023), against an average of -$161.0 million.
  • Year-over-year, Change in Cash plummeted 535.78% in 2021 and then surged 310.96% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$2.4 billion in 2021, then fell by 8.0% to -$2.6 billion in 2022, then skyrocketed by 82.02% to -$473.0 million in 2023, then plummeted by 266.38% to -$1.7 billion in 2024, then soared by 76.92% to -$400.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Change in Cash are -$400.0 million (Q4 2025), -$838.0 million (Q3 2025), and $1.3 billion (Q2 2025).